| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.11B | +1.0% | +2.3% |
| Cost of Revenue | $3.45B | -1.8% | -7.3% |
| Gross Profit | $2.66B | +4.9% | +18.3% |
| R&D Expense | $711.2M | -1.9% | +0.0% |
| SG&A Expense | $544.0M | +21.1% | +14.3% |
| Operating Income | $409.4M | -15.5% | +26.8% |
| Pre-tax Income | $601.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $8.34B | +30.6% | +0.4% |
| Accounts Receivable | $176.5M | +11.0% | +18.5% |
| Inventory | $166.6M | +20.6% | +41.0% |
| Current Assets | $22.07B | +12.0% | +6.2% |
| Total Assets | $39.18B | +6.3% | +7.8% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.96B | — | — |
| Capital Expenditures | $113.8M | — | — |
| Investing Cash Flow | -$671.8M | — | — |
| Financing Cash Flow | -$652.9M | — | — |
| Free Cash Flow | $1.84B | — | — |
| -8.8% |
| +85.6% |
| Income Tax | $139.9M | +15.6% | +225.3% |
| Net Income | $461.5M | -14.3% | +62.7% |
| EPS (Basic) | $0.76 | -13.6% | +65.2% |
| EPS (Diluted) | $0.74 | -14.9% | +64.4% |
| $10.11B |
| +0.4% |
| +0.7% |
| Long-term Debt | $7.29B | +42.5% | +19.4% |
| Total Liabilities | $16.71B | +13.4% | +1.6% |
| Stockholders' Equity | $22.51B | +1.6% | +13.0% |